| Name | Title | Contact Details | 
|---|---|---|
| Thomas Poche | Vice President, AGC, IP | Profile | 
| William Scarff | VP, Chief Litigation Counsel | Profile | 
| Michael Dusseau | Vice President, Compliance Operations | Profile | 
| Matthew Siccardi | Executive Director, Senior Counsel | Profile | 
| Lynne Bolduc | Vice President, Legal, Branded Pharma US | Profile | 
BioIntervene, Inc. is a preclinical-stage biopharmaceutical company committed to the discovery and development of effective and non-addictive medicines for chronic pain and other chronic inflammatory and neurodegenerative disorders. The Company was founded in 2014 based on insights from research at Saint Louis University and the National Institutes of Health (NIH). BioIntervene`s founding team has pioneered the understanding of adenosine A3 receptor biology, with a focus on developing first-in-class, selective adenosine A3 receptor agonists. California, United States Read more at CB Insights: https://www.cbinsights.com/company/biointervene
NeuroVasc Technologies is a developer of mechanical thrombectomy solutions for revascularization of the brain.
Biocentric Solutions, Inc. is a Madison, WI-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Changing lives with next generation peptide therapeutics
Marlon Ramos at Frange Blue-Hairstylist is a San Francisco, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.